Cargando…
Handbook of polymers for pharmaceutical technologies : volume 3, biodegradable polymers /
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken, NJ :
Wiley,
2015.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Half Title page; Title page; Copyright page; Dedication; Preface; Chapter 1: Bioactive Polysaccharides of Vegetable and Microbial Origins: An Overview; 1.1 Introduction; 1.2 Anticarcinogenic Polysaccharides; 1.3 Anti-inflammatory/Immunostimulating Polysaccharides; 1.4 Antiviral Polysaccharides; 1.5 Antioxidant Polysaccharides; 1.6 Other Biotechnological Applications; 1.7 Conclusions and Future Perspectives; Acknowledgments; References; Chapter 2: Chitosan: An Emanating Polymeric Carrier for Drug Delivery; 2.1 Introduction; 2.2 Preparation of Chitosan.
- 2.3 Physicochemical Properties of Chitosan2.4 Biological Activities of Chitosan; 2.5 Pharmaceutical Applications of Chitosan; 2.6 Functionalization of Chitosan; 2.7 Conclusion and Future Perspectives; References; Chapter 3: Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications; 3.1 Introduction; 3.2 The Fungal Cell; 3.3 Polysaccharides Produced by Fungi; 3.4 Production and Extraction of Polysaccharides from Fungi; 3.5 Fungal Polysaccharides in Biomedical and Pharmaceutical Applications.
- 3.6 Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications3.7 Conclusion and Future Perspective; References; Chapter 4: Environmentally Responsive Chitosan-based Nanocarriers (CBNs); 4.1 Introduction; 4.2 Graft Copolymerized CBNs; 4.3 pH-Sensitive CBNs; 4.4 Thermosensitive CBNs; 4.5 pH-Sensitive and Thermosensitive CBNs; 4.6 pH- and Ionic-Sensitive CBNs; 4.7 Photosensitive CBNs; 4.8 Electrical-Sensitive CBNs; 4.9 Magneto-Responsive CBNs; 4.10 Chemo-Sensitive CBNs; 4.11 Biodegradation of Chitosan and Its Derivatives; 4.12 Toxicity of CBNs.
- 4.13 Conclusions and Future PerspectivesReferences; Chapter 5: Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications; 5.1 Introduction; 5.2 Biodegradable Polymers in Biomedical Applications
- Relevant Aspects; 5.3 Biodegradable Natural Polymers in Pharmaceutical Applications; 5.4 Micro- and Nanocrystalline Natural Polymers and Fibrils
- General Regulative Considerations; 5.5 Concluding Remarks and Outlook; References; Chapter 6: Modification of Cyclodextrin for Improvement of Complexation and Formulation Properties; Abbrevations:; 6.1 Introduction.
- 6.2 Cyclodextrin and Its Degradation6.3 Complexation by CDs and Release; 6.4 Modifications and Scope with Respect to Pharmaceutical Application; 6.5 Concluding Remarks; Acknowledgements; References; Chapter 7: Cellulose-, Ethylene Oxide- and Acrylic-Based Polymers in Assembled Module Technology (Dome Matrix®); 7.1 Dome Matrix® Technology; 7.2 Polymers for Controlled Drug Release; 7.3 Cellulose Derivatives; 7.4 Acrylic Acid Polymers; 7.5 Polymethacrylates; 7.6 Polyethylene Oxide; 7.7 Conclusions; Acknowledgments; References; Chapter 8: Structured Biodegradable Polymers for Drug Delivery.